Literature DB >> 6151755

The effect of nicergoline on the lower urinary tract muscle.

M Caine, B Mazouz, B M Rossini.   

Abstract

Two series of experiments were performed to determine whether nicergoline possesses an alpha-adrenergic blocking action on the lower urinary tract musculature in dogs and humans. One series consisted of in vivo studies of urethral pressure profile recordings in 19 female dogs, and their responses to adrenergic stimulation with noradrenaline or methoxamine, alone and following administration of nicergoline. The other series consisted of in vitro isometric studies of 61 strips of human prostate, and the establishment of dose response curves to nor-adrenaline alone and in the presence of various concentrations of nicergoline. In both sets of experiments clear evidence of an alpha-adrenergic blocking effect was obtained. From the in vitro experiments, the Kb of nicergoline was calculated as less than or equal to 9 X 10(-9) M.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151755     DOI: 10.1007/BF00258037

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  7 in total

1.  Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck.

Authors:  M Caine; S Raz; M Zeigler
Journal:  Br J Urol       Date:  1975-04

2.  Adrenergic receptors in the female canine urethra.

Authors:  S Raz; M Caine
Journal:  Invest Urol       Date:  1972-01

3.  Vasodilating and alpha-receptor blocking activity of a new ergoline derivative.

Authors:  G Arcari; L Dorigotti; G B Fregnan; A H Glässer
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

4.  The urethral pressure profile.

Authors:  M Brown; J E Wickham
Journal:  Br J Urol       Date:  1969-04

5.  Study of the protection on afforded by nicergoline against the effects of cerebral ischemia in the cat.

Authors:  F Boismare; J Lorenzo
Journal:  Arzneimittelforschung       Date:  1975-03

6.  [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].

Authors:  M Lievre; M Ollagnier; G Faucon
Journal:  Arzneimittelforschung       Date:  1979

7.  Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.

Authors:  F Ronchi; A Margonato; R Ceccardi; P Rigatti; B M Rossini
Journal:  Urol Res       Date:  1982
  7 in total
  1 in total

Review 1.  Therapeutic use of nicergoline.

Authors:  Bengt Winblad; Mario Fioravanti; Tomas Dolezal; Inara Logina; Ivan Gospodinov Milanov; Dinu Cristian Popescu; Alina Solomon
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.